SIGA Tech (SIGA) Says Delaware Court Enters Motion of Reconsideration Over ST-246 Rights
Tweet
Share
E-mailGet Alerts SIGA Hot Sheet
Join SI Premium – FREE
SIGA Technologies, Inc. (Nasdaq: SIGA), reports that the Delaware Chancery Court has denied its motion for reconsideration of certain aspects of the Court's post-trial decision in the litigation brought by PharmAthene, Inc. over rights to ST-246.
As previously disclosed, the parties are now obliged to attempt to agree on language that will implement the Court's post-trial decision or, failing such agreement, submit their respective proposals for implementing language to the Court for decision. Once the Court enters a final judgment implementing the post-trial decision, SIGA intends to appeal the decision and judgment to the Delaware Supreme Court.
As previously disclosed, the parties are now obliged to attempt to agree on language that will implement the Court's post-trial decision or, failing such agreement, submit their respective proposals for implementing language to the Court for decision. Once the Court enters a final judgment implementing the post-trial decision, SIGA intends to appeal the decision and judgment to the Delaware Supreme Court.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sky Quarry names Heidi Bowman as CFO
- Agroz faces Nasdaq delisting over bid price and filing failures
- Albemarle names Max Hood as chief accounting officer
Create E-mail Alert Related Categories
Corporate News, FDA, LitigationSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
